B-cell-related genes account for much of this downregulation, which is likely linked to the 50% increase in nasopharyngitis, upper respiratory tract infections, and herpes infections compared to IFN-β, to potential long-term risk, and to doubling of COVID severity (1, 2, 61). The gene discussed is IFNB1; the disease is Recurrent upper respiratory tract infections.